These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 20233274)
1. Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction. Sette A; Martino A; Lioy E; Calò L J Cardiovasc Electrophysiol; 2010 Jul; 21(7):815-7. PubMed ID: 20233274 [TBL] [Abstract][Full Text] [Related]
2. Reversal of tachycardiomyopathy due to left atrial tachycardia by ivabradine. Bohora S; Lokhandwala Y; Parekh P; Vasavda A J Cardiovasc Electrophysiol; 2011 Mar; 22(3):340-2. PubMed ID: 20653812 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments. Kaplinsky E; Comes FP; Urondo LS; Ayma FP Cardiol J; 2010; 17(2):166-71. PubMed ID: 20544616 [TBL] [Abstract][Full Text] [Related]
4. Inappropriate sinus tachycardia in a heart transplant successfully treated with ivabradine. Mehta N; Bapat A; Tedrow U; Stevenson WG; Koplan B Europace; 2017 Jul; 19(7):1100. PubMed ID: 28431002 [No Abstract] [Full Text] [Related]
5. Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case report. Schulze V; Steiner S; Hennersdorf M; Strauer BE Cardiology; 2008; 110(3):206-8. PubMed ID: 18057886 [TBL] [Abstract][Full Text] [Related]
6. Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator. Adler A; Rosso R; Meir I; Viskin S Europace; 2013 Mar; 15(3):362-5. PubMed ID: 23118003 [TBL] [Abstract][Full Text] [Related]
7. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial. Danchin N Therapie; 2009; 64(2):111-4. PubMed ID: 19664404 [TBL] [Abstract][Full Text] [Related]
8. Treatment of inappropriate sinus tachycardia with ivabradine in a patient with postural orthostatic tachycardia syndrome and a dual chamber pacemaker. Khan S; Hamid S; Rinaldi C Pacing Clin Electrophysiol; 2009 Jan; 32(1):131-3. PubMed ID: 19140923 [TBL] [Abstract][Full Text] [Related]
10. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index. Fischer-Rasokat U; Honold J; Lochmann D; Wolter S; Liebetrau C; Fichtlscherer S; Möllmann H; Spyridopoulos I; Hamm CW Clin Res Cardiol; 2016 Jun; 105(6):527-34. PubMed ID: 26687495 [TBL] [Abstract][Full Text] [Related]
11. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart. Rivinius R; Helmschrott M; Ruhparwar A; Rahm AK; Darche FF; Thomas D; Bruckner T; Ehlermann P; Katus HA; Doesch AO Clin Res Cardiol; 2018 Feb; 107(2):138-147. PubMed ID: 29098378 [TBL] [Abstract][Full Text] [Related]
12. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction. Reil JC; Reil GH; Böhm M Trends Cardiovasc Med; 2009 Jul; 19(5):152-7. PubMed ID: 20005474 [TBL] [Abstract][Full Text] [Related]
13. A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine. Winum PF; Cayla G; Rubini M; Beck L; Messner-Pellenc P Pacing Clin Electrophysiol; 2009 Jul; 32(7):942-4. PubMed ID: 19572874 [TBL] [Abstract][Full Text] [Related]
14. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients. Doesch AO; Ammon K; Konstandin M; Celik S; Kristen A; Frankenstein L; Buss S; Hardt S; Sack FU; Katus HA; Dengler TJ Transplantation; 2009 Sep; 88(6):835-41. PubMed ID: 19920784 [TBL] [Abstract][Full Text] [Related]
15. Ivabradine to treat inappropriate sinus tachycardia after the fast pathway ablation in a patient with severe pectus excavatum. Capulzini L; Sarkozy A; Semeraro O; Paparella G; Chierchia GB; DE Asmundis C; Roos M; Yazaki Y; Muller-Burri A; Sorgente A; Brugada P Pacing Clin Electrophysiol; 2010 Mar; 33(3):e32-5. PubMed ID: 19821934 [TBL] [Abstract][Full Text] [Related]
16. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. Ptaszynski P; Kaczmarek K; Ruta J; Klingenheben T; Wranicz JK Europace; 2013 Jan; 15(1):116-21. PubMed ID: 22772053 [TBL] [Abstract][Full Text] [Related]
17. The use of ivabradine for inappropriate sinus tachycardia. Weyn T; Stockman D; Degreef Y Acta Cardiol; 2011 Apr; 66(2):259-62. PubMed ID: 21591589 [TBL] [Abstract][Full Text] [Related]
18. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction. Perry CM Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944 [TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. Cappato R; Castelvecchio S; Ricci C; Bianco E; Vitali-Serdoz L; Gnecchi-Ruscone T; Pittalis M; De Ambroggi L; Baruscotti M; Gaeta M; Furlanello F; Di Francesco D; Lupo PP J Am Coll Cardiol; 2012 Oct; 60(15):1323-9. PubMed ID: 22981555 [TBL] [Abstract][Full Text] [Related]